Endonovo Therapeutics, Inc. ENDV 0.01 Endonovo Therapeutics, Inc.

Home
  /  
Stock List  /  Endonovo Therapeutics, Inc.
Range:7.0E-4-0.016Vol Avg:779543Last Div:0Changes:0
Beta:-0.62Cap:0.00BCurrency:USDExchange:PNK
Sector:HealthcareIPO:Thu Nov 15 2012Empoloyees:1
CUSIP:29272H300CIK:0001528172ISIN:US29272H3003Country:US
CEO:Mr. Alan Brian CollierWebsite:https://www.endonovo.com
Endonovo Therapeutics, Inc., a biotechnology company, develops, manufactures, and distributes non-invasive Electroceutical medical devices for regenerative medicine. The company offers SofPulse, a non-invasive Electroceutical therapeutic device for the palliative treatment of soft tissue injuries, chronic wounds, and post-operative pain and edema. Its Electroceuticals medical device is also used for the treatment of inflammation, wounds, cardiovascular diseases, chronic kidney diseases, liver diseases, non-alcoholic steatohepatitis, peripheral artery diseases, and ischemic stroke, as well as for central nervous system disorders, such as traumatic brain injury, acute concussions, post-concussion syndrome, and multiple sclerosis. Endonovo Therapeutics, Inc. was founded in 2008 and is based in Woodland Hills, California.

Stock Details

The content provided on this site is for informational purposes only and does not constitute financial, investment, or professional advice. We are not registered investment advisors or financial planners, and we do not provide recommendations or advice on buying, selling, or holding any particular stocks or securities. Any investment decisions should be made based on your own research and consultation with a qualified financial professional. We are not responsible for any financial loss or damages incurred from reliance on the information provided on this site. Please invest responsibly and seek professional advice when needed.
DMCA.com Protection StatusPowered by StackThrow